Table 1.
Descriptive Statistics of the Advanced-HGSOC Cohort.
| Variables (n = 209) | Frequency | Percent (%) |
|---|---|---|
| Age, year, mean, SD (range) | 64.6±10.6 (41–85) | |
| Surgical Complexity Score (SCS) | ||
| Low (1–3) | 124 | 59.3 |
| Moderate (4–7) | 76 | 36.4 |
| High (8–12) | 9 | 4.3 |
| Radiological dissemination patterns | ||
| Intraperitoneal | 134 | 64.1 |
| Intraperitoneal and lymphatic | 59 | 28.2 |
| Intraperitoneal and haematogenous | 16 | 7.7 |
| Operation time, mean, SD (min-max) | 177±77 (45–485) | |
| Disease score | ||
| Pelvis (1) | 10 | 4.8 |
| Lower abdomen (2) | 187 | 89.5 |
| Upper abdomen (3) | 12 | 5.7 |
| Timing of surgery | ||
| PDS | 46 | 20 |
| IDS | 163 | 80 |
| Residual disease | ||
| R0 | 160 | 76.5 |
| R1 | 39 | 18.7 |
| R2 | 10 | 4.8 |
| Chemotherapy | ||
| Carboplatin+Taxol | 134 | 64.1 |
| Carboplatin+Taxol+Bevascusimab | 22 | 10.5 |
| Carbo+Taxol+PARP inhibitor | 25 | 12.0 |
| Carboplatin only | 22 | 10.5 |
| No | 6 | 2.9 |